Expertise

Dr. Ramakrishnan's laboratory is investigating hypoxia-driven changes in the tumor microenvironment. These studies are focusing on micro-RNA network and cellular iron homeostasis modulating gut microbiome, tumor angiogenesis and immunophenotype of ovarian cancer. He and his team are developing autologous cancer vaccines based on genetically engineered super antigens to induce immune response against peritoneal metastasis.


Research interests: Tumor angiogenesis – Antiangiogenic Gene Therapy.

Links

Organizational Affiliations

UMMG Department of Surgery, Miller School of Medicine, Medical Campus, University of Miami

Miller School of Medicine, Medical Campus, University of Miami

UMMG Dept of Surgery - Div of Surgical Oncology, Miller School of Medicine, Medical Campus, University of Miami

Education

Biochemistry
1980, PhD, All India Institutes of Medical Sciences, India
Biology
1972, MS, Madurai University